Product Description Model NO.: CAS: 168273-06-1 Customized: Non-Customized Suitable for: Adult Purity: >99% CAS: 168273-06-1 Usage: Weight Loss Specification: 25kg/drum Powder: Yes Certification: ISO 9001, USP, BP State: Solid Product Name: Rimonabant Appearance: White Powder Trademark: QA Origin: China Weight losss Steroid Powder Rimonabant  for Body Shape (CAS: 168273-06-1)

Rimonaban
Synonyms: ACOMPLIA;RIMONABANT;RIMONABANT(ACOMPLIA,SR141716);5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidinopyrazole-3-carboxamide;1H-Pyrazole-3-carboxamide, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-;5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide;A 281;Sr 141716
CAS: 168273-06-1
MF: C22H21Cl3N4O
MW: 463.79
Product Categories: Weight Loss;SR141716
Mol File: 168273-06-1.mol
Usage: Rimonabant is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane ;Mainly used for weight loss .

Product description:

Rimonabant is a weight loss drug, Sanofi-Aventis by the French company successfully developed for the treatment of obesity is the first cannabinoid type 1 receptor (CB1) antagonist, by selectively blocking the EC system cannabis Su -1 (cannabinoid-1, CB1) receptors play a role, can significantly reduce weight, reduce waist circumference, reducing risk factors for cardiovascular disease, but also can improve blood lipids and insulin resistance and metabolic syndrome, especially for the existence of clinical obesity or heart disease risk for people.

Application :

Rimonabant for the new weight-loss drug, can be applied to smoking cessation. A new weight-loss drug rimonabant (Rimonabant), not only can lose weight, but also lower blood pressure, cholesterol and blood sugar, domestically year clinical study found that subjects taking one to two months later, weight Save an average of six to eight kilograms.

The other fuction of quit smoking :

Rimonabant may also be found to be effective in assisting some smokers to quit smoking. Sanofi is currently conducting studies to determine the possible value of rimonabant in smoking-cessation therapy. The Studies with Rimonabant and Tobacco Use (STRATUS) program involves more than 6,000 subjects. STRATUS is designed to explore two smoking-related therapies: first, to use rimonabant directly to aid in smoking cessation; second, to help prevent weight gain in former smokers. Initial results apparently suggest rimonabant is effective for both uses. However, the FDA has explicitly stated to Sanofi that, without additional studies, rimonabant cannot be approved in the United States for smoking cessation therapy.

Specifications:



We supply many kinds of pharmaceutical raw materials (weight loss powder ,anabolic steroids and peptides),any needs please contact me by www.quality-steroid.com 
Welcome to your inquiry !

Contact us if you need more details on Rimonabant. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Weight Loss、Body Shape. If these products fail to match your need, please contact us and we would like to provide relevant information.

Product Categories : Pharmaceutical Intermediate